Phase II study of a three-day schedule of topotecan plus paclitaxel and carboplatin on day three in the initial treatment of advanced ovarian and primary peritoneal carcinoma.

Trial Profile

Phase II study of a three-day schedule of topotecan plus paclitaxel and carboplatin on day three in the initial treatment of advanced ovarian and primary peritoneal carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2013

At a glance

  • Drugs Carboplatin; Paclitaxel; Topotecan
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2011 Actual end date (1 Jun 2006) added as reported by ClinicalTrials.gov.
    • 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top